Biotechnology Jobs

• London
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Individual-contributor alliance lead owning an established central laboratory partnership, balancing strategic direction with hands-on governance. Runs governance forums, monitors KPIs and study delivery, resolves urgent operational issues, and embeds a new operating model, using AI tools to analyse large datasets.

Claude

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• London
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

• Zebulon, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across the global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Partners with GSC Quality, MSAT and R&D on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Upper Merion
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Collaborates with GSC Quality, MSAT and R&D, benchmarks industry best practice, and establishes KPIs and reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Belgium-Wavre
• €148,500 – €247,500 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Acts as the single point of contact in GSC Strategy, collaborating with Quality, MSAT and R&D, benchmarking industry practice and reporting KPIs to senior leadership.

• Warsaw, Poland
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and contributes to business development diligence.

Real World Evidence (RWE)

• London
• On-site
• US$242,550 – US$404,250 pa
• Director · manages people

Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and interacts with regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Poznan Grunwaldzka
• Hybrid
• £410,250 – £683,750 pa
• Director

Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.

• Siena, Italy
• Hybrid
• £81,750 – £136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.

• Stevenage
• Hybrid · 2 days in office
• US$284,625 – US$474,375 pa
• Director · manages people

Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Provides medical monitoring and safety oversight, leads the clinical matrix team, and engages with regulators, KOLs and cross-functional partners in a hybrid working model.

• Waltham, United States
• Hybrid · 2 days in office
• US$284,625 – US$474,375 pa
• Director · manages people

Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Serves as clinical lead for a matrix team, providing medical monitoring, regulatory input and safety oversight while working with biology, regulatory, commercial and operations colleagues.